Telomir Pharmaceuticals' Telomir-1 Shows Promise in Reversing Macular Degeneration in Preclinical Study
Telomir Pharmaceuticals announces positive preclinical results for Telomir-1 in reversing retinal degeneration in zebrafish model of AMD. Learn how this breakthrough could lead to regenerative treatments for macular degeneration.
This news matters as Telomir Pharmaceuticals' breakthrough in reversing retinal degeneration in a zebrafish model of AMD could lead to potential regenerative treatments for age-related macular degeneration, offering hope for improved vision and quality of life for patients.